flucytosine has been researched along with Co-infection in 7 studies
Flucytosine: A fluorinated cytosine analog that is used as an antifungal agent.
flucytosine : An organofluorine compound that is cytosine that is substituted at position 5 by a fluorine. A prodrug for the antifungal 5-fluorouracil, it is used for the treatment of systemic fungal infections.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Amphotericin B deoxycholate (AmBd) is the recommended induction treatment for HIV-associated cryptococcal meningitis (CM)." | 9.20 | Toxicity of Amphotericin B Deoxycholate-Based Induction Therapy in Patients with HIV-Associated Cryptococcal Meningitis. ( Bicanic, T; Bottomley, C; Brouwer, AE; Harrison, TS; Hosseinipour, MC; Jackson, A; Jarvis, JN; Limmathurotsakul, D; Loyse, A; Meintjes, G; Muzoora, C; Phulusa, J; Taseera, K; van der Horst, C; White, NJ; Wilson, D; Wood, R, 2015) |
| "Amphotericin B deoxycholate (AmBd) is the recommended induction treatment for HIV-associated cryptococcal meningitis (CM)." | 5.20 | Toxicity of Amphotericin B Deoxycholate-Based Induction Therapy in Patients with HIV-Associated Cryptococcal Meningitis. ( Bicanic, T; Bottomley, C; Brouwer, AE; Harrison, TS; Hosseinipour, MC; Jackson, A; Jarvis, JN; Limmathurotsakul, D; Loyse, A; Meintjes, G; Muzoora, C; Phulusa, J; Taseera, K; van der Horst, C; White, NJ; Wilson, D; Wood, R, 2015) |
| " The objective of this study was to compare the survival benefit between 5-FC (flucytosine) and fluconazole as second-line drugs given in combination with AmB." | 2.50 | Comparison of flucytosine and fluconazole combined with amphotericin B for the treatment of HIV-associated cryptococcal meningitis: a systematic review and meta-analysis. ( Lin, DF; Lu, X; Shen, C; Yao, ZW, 2014) |
| "The present study showed that mixed infections exist and could be of particular importance for care outcomes." | 1.51 | Cryptococcus genetic diversity and mixed infections in Ivorian HIV patients: A follow up study. ( Bellet, V; Bertout, S; Chabrol, A; Delaporte, E; Doumbia, A; Drakulovski, P; Kakou, A; Kassi, FK; Krasteva, D; Landman, R; Menan, HEI; Reynes, J; Roger, F, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kassi, FK | 1 |
| Drakulovski, P | 1 |
| Bellet, V | 1 |
| Roger, F | 1 |
| Chabrol, A | 1 |
| Krasteva, D | 1 |
| Doumbia, A | 1 |
| Landman, R | 1 |
| Kakou, A | 1 |
| Reynes, J | 1 |
| Delaporte, E | 1 |
| Menan, HEI | 1 |
| Bertout, S | 1 |
| Loyse, A | 2 |
| Burry, J | 1 |
| Cohn, J | 1 |
| Ford, N | 1 |
| Chiller, T | 1 |
| Ribeiro, I | 1 |
| Koulla-Shiro, S | 1 |
| Mghamba, J | 1 |
| Ramadhani, A | 1 |
| Nyirenda, R | 1 |
| Aliyu, SH | 1 |
| Wilson, D | 2 |
| Le, T | 1 |
| Oladele, R | 1 |
| Lesikari, S | 1 |
| Muzoora, C | 2 |
| Kalata, N | 1 |
| Temfack, E | 1 |
| Mapoure, Y | 1 |
| Sini, V | 1 |
| Chanda, D | 1 |
| Shimwela, M | 1 |
| Lakhi, S | 1 |
| Ngoma, J | 1 |
| Gondwe-Chunda, L | 1 |
| Perfect, C | 1 |
| Shroufi, A | 1 |
| Andrieux-Meyer, I | 1 |
| Chan, A | 1 |
| Schutz, C | 1 |
| Hosseinipour, M | 1 |
| Van der Horst, C | 2 |
| Klausner, JD | 1 |
| Boulware, DR | 1 |
| Heyderman, R | 1 |
| Lalloo, D | 1 |
| Day, J | 1 |
| Jarvis, JN | 2 |
| Rodrigues, M | 1 |
| Jaffar, S | 1 |
| Denning, D | 1 |
| Migone, C | 1 |
| Doherty, M | 1 |
| Lortholary, O | 1 |
| Dromer, F | 2 |
| Stack, M | 1 |
| Molloy, SF | 1 |
| Bicanic, T | 2 |
| van Oosterhout, J | 1 |
| Mwaba, P | 1 |
| Kanyama, C | 1 |
| Kouanfack, C | 1 |
| Mfinanga, S | 1 |
| Govender, N | 1 |
| Harrison, TS | 2 |
| Yao, ZW | 1 |
| Lu, X | 1 |
| Shen, C | 1 |
| Lin, DF | 1 |
| Kamikawa, Y | 1 |
| Mori, Y | 1 |
| Nagayama, T | 1 |
| Fujisaki, J | 1 |
| Hirabayashi, D | 1 |
| Sakamoto, R | 1 |
| Hamada, T | 1 |
| Sugihara, K | 1 |
| Gariani, K | 1 |
| Rougemont, M | 1 |
| Renzi, G | 1 |
| Hibbs, J | 1 |
| Emonet, S | 1 |
| Schrenzel, J | 1 |
| Desnos-Ollivier, M | 1 |
| Patel, S | 1 |
| Raoux-Barbot, D | 1 |
| Heitman, J | 1 |
| Bottomley, C | 1 |
| Brouwer, AE | 1 |
| Taseera, K | 1 |
| Jackson, A | 1 |
| Phulusa, J | 1 |
| Hosseinipour, MC | 1 |
| Limmathurotsakul, D | 1 |
| White, NJ | 1 |
| Wood, R | 1 |
| Meintjes, G | 1 |
2 reviews available for flucytosine and Co-infection
| Article | Year |
|---|---|
Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries.
Topics: Africa; Amphotericin B; Antifungal Agents; Coinfection; Cryptococcus neoformans; Developing Countrie | 2019 |
Comparison of flucytosine and fluconazole combined with amphotericin B for the treatment of HIV-associated cryptococcal meningitis: a systematic review and meta-analysis.
Topics: Amphotericin B; Antifungal Agents; Coinfection; Drug Therapy, Combination; Fluconazole; Flucytosine; | 2014 |
1 trial available for flucytosine and Co-infection
| Article | Year |
|---|---|
Toxicity of Amphotericin B Deoxycholate-Based Induction Therapy in Patients with HIV-Associated Cryptococcal Meningitis.
Topics: Adult; Amphotericin B; Anemia; Antifungal Agents; Blood Cell Count; Coinfection; Creatinine; Cryptoc | 2015 |
4 other studies available for flucytosine and Co-infection
| Article | Year |
|---|---|
Cryptococcus genetic diversity and mixed infections in Ivorian HIV patients: A follow up study.
Topics: Adult; Amphotericin B; Antifungal Agents; Coinfection; Cryptococcosis; Cryptococcus; Cryptococcus ne | 2019 |
Frequency of clinically isolated strains of oral Candida species at Kagoshima University Hospital, Japan, and their susceptibility to antifungal drugs in 2006-2007 and 2012-2013.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Autoimmune Diseases; Bacterial Lo | 2014 |
Fulminant atypical Cryptococcus neoformans pneumonia confirmed by PLEX-ID.
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Bronchoalveolar Lavage Fluid; Coinfection; | 2014 |
Cryptococcosis Serotypes Impact Outcome and Provide Evidence of Cryptococcus neoformans Speciation.
Topics: Antifungal Agents; Cerebrospinal Fluid; Coinfection; Cryptococcosis; Cryptococcus neoformans; Flucyt | 2015 |